Clinical characteristics of Rett Syndrome

##plugins.themes.academic_pro.article.sidebar##

Published Oct 27, 2011
Download
pdf
Vol. 89 No. 10 (2011): Issue Oct 2011

##plugins.themes.academic_pro.article.main##

Zeineb Abbes
Asma Bouden
Soumaya Halayem
Sami Othman
Mohamed Béchir Halayem

Abstract

Background: Rett Syndrome is a neurodevelopmental disorder, one of the least commonly occurring autism spectrum disorders (ASD),affecting mainly females.
Aim: To describe features and molecular specificities of Rett syndrome.
Methods: To identify articles for this review, a Pubmed search was conducted using the following keywords: Rett syndrome, regression,mutation, stereotypes.
Results: This syndrome is characterized by cognitive impairment,communication dysfunction, stereotypic movement disorder, and growth failure. It is generally caused by mutations in the MECP2 gene. Rett Syndrome has a prevalence ranging from 10-20 000 females. Specific treatement is not available, but patients need a careful planning for long-term care, with multidisciplinary approaches.

Keywords:

Rett syndrome; regression; mutation; stereotypes

##plugins.themes.academic_pro.article.details##

References

  1. Rett A. Uber ein eigenartiges hirnatrophisches Syndrom bei Hyperammonamie im Kindesalter [On an unusual brain atrophic syndrome with hyperammonemia in childhood]. Wien med Wochenschrift 1966; 116: 723-6.
  2. Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983; 14: 471-9.
  3. Laurvick CL, De Klerk N, Bower C, et al. Rett syndrome in Australia: A review of the epidemiology. J Pediatr 2006; 148: 347-52.
  4. Moog U, Smeets E, Roozendal KV, et al. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neur 2003; 7: 5-12.
  5. Hagberg B, Witt-Engerstrom I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet 1986 ; 1 : 47-59.
  6. Bahi-Buisson N. LE SYNDROME DE RETT ; une encéphalopathie dominante liée à l'X. Neurol 2004 ; 7 : 549-553.
  7. Young D, Nagarajan L, de Klerk N, Jacoby P, Ellaway C, Leonard H. Sleep problems in Rett syndrome. Brain Dev 2007; 29: 609-16.
  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM IV). Washington DC: APA, 1994. Traduction française: Manuel diagnostique et statistique des troubles mentaux. Paris: Masson, 2000.
  9. Organisation mondiale de la santé. Classification Internationale des Troubles Mentaux et des Troubles du Comportement. CIM 10/ ICD 10. Critères diagnostiques pour la recherche. Paris: Masson, 1994.
  10. The Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol 1988; 23: 425-28.
  11. Naidu S, Bibat G, Kratz L, et al. Clinical variability in Rett syndrome. J Child Neurol 2003; 18: 662-8.
  12. Matson JL, Fodstad JC, Boisjoli JA. Nosology and diagnosis of Rett Syndrome. Res Autism Spectr Disord 2008 ; 2 : 601-11.
  13. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat Genet 1999; 23: 185-88.
  14. Kriaucionis S, Bird A. DNA methylation and Rett syndrome. Hum Mol Genet 2003; 12: 221-227.
  15. Miltenberger-Miltenyi G, Laccone F. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat 2003; 22: 107- 15.
  16. Van den Veyver I, Zoghbi H. Methyl-CpG-binding protein 2 mutations in Rett syndrome. Genet Dev 2000; 10: 275-9.
  17. Monnerat LS, Moreira Ados S, Alves MC, Bonvicino CR, Vargas FR. Identification and characterization of novel sequence variations in MECP2 gene in Rett syndrome patients. Brain Dev. 2010; 32: 843-8.
  18. Philippe C, Villard L, De Roux N, et al. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. Eur. J. Med. Genet 2006 ; 49 : 9-18.
  19. Temudo T, Santos M, Ramos E, et al. Rett syndrome with and without detected MECP2 mutations: An attempt to redefine phenotypes. Brain Dev. 2011; 33: 69-76.
  20. Buoni S et al. EEG features and epilepsy in MECP2-mutated patients with the Zappella variant of Rett syndrome. Clin Neurophysiol 2010; 121: 652-57.
  21. Shahbazian MD, Antalffy B, Armstrong DL, et al. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002; 15:115-24.
  22. Glaze DG, Frost JD Jr., Zoghbi HY et al. Rett's syndrome. Correlation of electroencephalographic characteristics with clinical staging. Arch Neurol 1987; 44: 1053-6.
  23. Kirby R, Lane J, Childers J, et al. Longevity in Rett Syndrome: Analysis of the North American Database. J Pediatr 2010; 156: 135-8.
  24. Sigafoos J, Woodyatt G. Le Syndrome de Rett et ses implications pédagogiques. REMH 1996 ; 3 : 21 - 31.